VRCA
Price:
$0.8163
Market Cap:
$75.50M
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagio...[Read more]
Industry
Biotechnology
IPO Date
2018-06-15
Stock Exchange
NASDAQ
Ticker
VRCA
According to Verrica Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 348.29%. This represents a change of 237.23% compared to the average of 103.28% of the last 4 quarters.
The mean historical ROE of Verrica Pharmaceuticals Inc. over the last ten years is 7.15%. The current 348.29% ROE has changed 4.77% with respect to the historical average. Over the past ten years (40 quarters), VRCA's ROE was at its highest in in the December 2024 quarter at 164.32%. The ROE was at its lowest in in the March 2024 quarter at -1344.64%.
Average
7.15%
Median
-52.66%
Minimum
-338.99%
Maximum
776.66%
Discovering the peaks and valleys of Verrica Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 390.31%
Maximum Annual ROE = 776.66%
Minimum Annual Increase = -329.11%
Minimum Annual ROE = -338.99%
Year | ROE | Change |
---|---|---|
2024 | 776.66% | -329.11% |
2023 | -338.99% | 390.31% |
2022 | -69.14% | -42.05% |
2021 | -119.32% | -13.49% |
2020 | -137.93% | 220.84% |
2019 | -42.99% | 86.20% |
2018 | -23.09% | -56.16% |
2017 | -52.66% | -173.34% |
The current ROE of Verrica Pharmaceuticals Inc. (VRCA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
122.84%
5-year avg
22.26%
10-year avg
7.15%
Verrica Pharmaceuticals Inc.’s ROE is greater than Tarsus Pharmaceuticals, Inc. (-39.72%), greater than Aldeyra Therapeutics, Inc. (-72.57%), greater than Travere Therapeutics, Inc. (-1183.97%), greater than Eton Pharmaceuticals, Inc. (-23.41%), greater than Y-mAbs Therapeutics, Inc. (-30.59%), greater than Scholar Rock Holding Corporation (-118.22%), greater than Crinetics Pharmaceuticals, Inc. (-30.95%), greater than Kezar Life Sciences, Inc. (-62.32%),
Company | ROE | Market cap |
---|---|---|
-39.72% | $1.82B | |
-72.57% | $322.84M | |
-1183.97% | $1.43B | |
-23.41% | $402.80M | |
-30.59% | $195.22M | |
-118.22% | $3.87B | |
-30.95% | $2.91B | |
-62.32% | $31.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verrica Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verrica Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Verrica Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Verrica Pharmaceuticals Inc. (VRCA)?
What is the highest ROE for Verrica Pharmaceuticals Inc. (VRCA)?
What is the 3-year average ROE for Verrica Pharmaceuticals Inc. (VRCA)?
What is the 5-year average ROE for Verrica Pharmaceuticals Inc. (VRCA)?
How does the current ROE for Verrica Pharmaceuticals Inc. (VRCA) compare to its historical average?